Northern Kentucky’s St. Elizabeth Hospital the First Site to Dose COVID-19 Patients with PUL-042

St. Elizabeth Hospital in Edgewood, Kentucky, was selected as the first clinical investigational site for a Phase II clinical trial studying a new drug to treat COVID-19 called PUL-042, an inhalation solution under investigation to help COVID-19 from progressing in...

University of Kentucky: A Hub of Clinical Research in the Appalachian Region of America

Few understand the importance of clinical trials and their contribution to advancements in medicine. Even fewer understand the challenge in finding patients for studies. The University of Kentucky recently touted not only research but its commitment to advancing...

Pin It on Pinterest